Small US biotechs cite FDA barriers to first-in-human trials: survey

Reports

3

Domains carrying it

3

First reported

12 August 2026

Latest report

12 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 12 August 2026New Survey Finds U.S. Biotechs Advancing Treatments for Rare and Serious Diseases ...massbio.org
2. 12 August 2026New Survey Finds U.S. Biotechs Advancing Treatments for Rare and Serious Diseases ...lasvegassun.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• America's Next Biotech Challenge2 reports · 1 domains · 6 August 2026
• FDA Allows First Gene Therapy Clinical Trial for Ultra-Rare Pediatric Neurodegenerative Disease2 reports · 2 domains · 4 September 2026
• Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths5 reports · 4 domains · 3 September 2026
• U.S. Rare Disease Biotech Investing Rises After FDA's PRV Program Renewal: Report2 reports · 2 domains · 11 August 2026
• FDA Approves Gene Therapy for Glycogen Storage Disease Type 1a6 reports · 6 domains · 22 August 2026
• US FDA expands approval for J&J's drug for rare blood disorder2 reports · 2 domains · 25 August 2026

◆ Share

◆ Evidence

3 reports · 3 domains

• New Survey Finds U.S. Biotechs Advancing Treatments for Rare and Serious Diseases ...lasvegassun.com · 12 August 2026
• Small US biotechs cite FDA barriers to first-in-human trials: surveyallsci.com · 12 August 2026
• New Survey Finds U.S. Biotechs Advancing Treatments for Rare and Serious Diseases ...massbio.org · 12 August 2026